Bayer

Bayer appears in the book’s account of the commercial and scientific exploitation of Auschwitz: the company is named as testing new typhus drugs on camp inmates. The reference is brief, but it places a pharmaceutical firm within a system in which prisoners were subjected to harm for institutional and industrial purposes.

Bayer in the Auschwitz Account

The book names Bayer while describing the involvement of companies in Auschwitz. In the same passage, it says that prisoners were exploited as labor and gives examples of industrial production for IG Farben and Krupp. It then distinguishes Bayer’s role: testing new typhus drugs on inmates. The text does not provide dates, identify the researchers involved, or describe the trials’ procedures or outcomes.

Pharmaceutical Experimentation

Bayer’s mention belongs to a wider account of medical experimentation in the camp, but the passage does not attribute the experiments conducted by Josef Mengele or his prisoner-assistant Miklós Nyiszli to Bayer. It separately says that Schering Laboratories paid a colleague to conduct in-vitro fertilization experiments. These references identify different activities and should not be conflated: Bayer is associated here with testing typhus drugs, while the specific research attributed to Schering Laboratories is distinct.

Narrative Context and Limits

The reference occurs during Josef Mengele’s angry recollection of Auschwitz and his resentment that industrialists and other figures, as he sees it, prospered after the war while he remained in exile. The narrative places the named companies within a larger indictment of wartime exploitation, but it does not supply Bayer-specific information about profits, executives, later careers, or postwar accountability. Bayer’s significance in this account is therefore concentrated in the stated drug testing and in the book’s presentation of corporate activity as part of the camp’s wider system of exploitation.